COVID-19 infection in hypereosinophilic syndrome: A survey-based analysis

J Allergy Clin Immunol Pract. 2022 May;10(5):1371-1373.e20. doi: 10.1016/j.jaip.2022.02.019. Epub 2022 Mar 3.

Authors

David F Espinoza¹, Lauren Wetzler¹, Nicole Holland¹, Neshen Moodley², Jeananne Ware¹, Amy Klion¹, Paneez Khoury³

Affiliations

¹ National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Md.
² International Biomedical Research Support Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
³ National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Md. Electronic address: khouryp@niaid.nih.gov.

No abstract available

Publication types

Research Support, N.I.H., Intramural

MeSH terms

COVID-19*
Humans
Hypereosinophilic Syndrome* / diagnosis